WASHINGTON (Reuters) – The Biden administration is working with AstraZeneca to identify other facilities to produce its coronavirus vaccine after the contractor Emergent BioSolutions mixed up ingredients for two vaccines, White House spokeswoman Jen Psaki said on Monday.
AstraZeneca, whose vaccine has not been approved in the United States, said it will work with President Joe Biden’s administration to find an alternative site to produce its vaccine.
(Reporting by Andrea Shalal and Steve Holland; Editing by Chris Reese)
